Cramer's 'Stop Trading!': Cloud Peak IPO

NEW YORK (TheStreet) -- "This thing is going to work," said Jim Cramer on CNBC's "Stop Trading!" segment on Tuesday, referring to the upcoming IPO of Cloud Peak Energy."

He said people are overlooking it because "they think coal's dirty" and because they think President Obama's not a coal fan. But Cramer pointed to Warren Buffett's recent purchase of Burlington Northern ( BNI) as evidence that the IPO will be successful.

According to Cramer, the Burlington purchase is a sign from Buffett that coal's "going to be with us for a long time" and that Cloud Peak will be a "sleeper deal."

"In Buffett we trust," said Cramer. "People have to recognize that coal is here to stay, even with Obama."

Cramer further supported his position by mentioning the strength of the coal lobby and the country's "fixation with developing clean coal. Cloud Peak's coal, he said, is "the cleanest coal in the country."

Turning to retail, Cramer said the "people are missing the point." He told viewers to consider companies such as Palm ( PALM), Research In Motion ( RIMM) and Apple ( AAPL), which make expensive smartphones. "The consumer is spending," said Cramer. "They may not be spending at Target ( TGT), but they're willing to spend a fortune on phones."

-- Written by Rebecca Corvino in New York.
Most Popular Today
Five Cheap Stocks on the Rise
Most Commented Today
Motorola Droid Lands Hard on Palm

(Editor's note: At the time of publication, Cramer owned XXX for his Action Alerts PLUS charitable trust.)

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says